Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
Open Access
- 19 April 2021
- journal article
- editorial
- Published by Elsevier BV in Kidney International
- Vol. 99 (6), 1275-1279
- https://doi.org/10.1016/j.kint.2021.04.007
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Persistence of antibody response to SARS-CoV-2 in a cohort of haemodialysis patients with COVID-19Nephrology Dialysis Transplantation, 2021
- The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to actionKidney International, 2021
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionScience, 2021
- Maturation and persistence of the anti-SARS-CoV-2 memory B cell responseCell, 2021
- Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unitKidney International, 2021
- SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virusCommunications Biology, 2021
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsThe New England Journal of Medicine, 2020
- Significant impact of COVID-19 on organ donation and transplantation in a low-prevalence country: AustraliaKidney International, 2020
- Outcomes of patients with end-stage kidney disease hospitalized with COVID-19Kidney International, 2020
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controlsNature, 2020